Sponsor Pipeline

University of Geneva, Switzerland Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
11
Active Trials
3
Recruiting
1
Phase 3
8
Disease Areas
What Changed in the Last 30 Days
First PostedNew Trial FilingPhaseStatus
2026-07-23 NCT07721233 Virtual-reality Induced Immune Modulation in Allergic Patients Not Yet Recruiting
Active Trials by Phase
Phase 4
1
Phase 3
1
Not specified
9
Active Trials
NCT IDTitleConditionStatus
Phase 4
NCT04669717 Antibiotics as Adjuncts to Periodontal Therapy:Pharmacokinetic Considerations and Dosing… Periodontal Diseases Recruiting
Phase 3
NCT07461675 Effects of Neoadjuvant Immunotherapy on Anti-tumour Immunity in Hepatocellular Carcinoma… Hepato Cellular Carcinoma (HCC) Not Yet Recruiting
Not specified
NCT04713800 Two-unit Cantilever Implant Prostheses Made of Monolithic Zirconia or PFM Jaw, Edentulous, Partially Recruiting
NCT05512169 Pharmacogenomic Association Study in Indian Children With Acute Lymphoblastic Leukemia ALL, Childhood Recruiting
NCT06191835 Implementation of a New Model of Care for Supporting Long-term Medication Adherence… Medication Initiation for Long-term Conditions Active, Not Recruiting
NCT04845529 Improving Awareness for Spatial Neglect With tDCS Stroke Not Yet Recruiting
NCT04957576 The Disrupted Bodily Self of Patients Stroke Not Yet Recruiting
NCT07036471 Supporting Patients Starting New Medicines: Evaluating the myCare Start Service in… Cardio-vascular Disease Not Yet Recruiting
NCT07072338 Promoting Mental and Cognitive Health in Old Age Through Scalable Evidence-based… Well-Being, Psychological Not Yet Recruiting
NCT07345858 Salivary Oxytocin as a Biomarker of Psychedelic Treatment Major Depressive Disorder (MDD) Enrolling by Invitation
NCT07721233 Virtual-reality Induced Immune Modulation in Allergic Patients Hymenoptera Venom Allergy Not Yet Recruiting
Disease Areas
Get alerts when University of Geneva, Switzerland's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free